| A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson’s disease B Aktas, B Aslim, DA Ozdemir Scientific Reports 14 (1), 15460, 2024 | | 2024 |
| Biochemical and Molecular Characterizations of a Novel pH- and Temperature-Stable Pectate Lyase from Bacillus amyloliquefaciens S6 for Industrial Application S Bekli, B Aktas, D Gencer, B Aslim Molecular biotechnology 61, 681-693, 2019 | 25 | 2019 |
| Evaluation of probiotic activity of Lactobacillus casei strains B Aktas The University of Wisconsin-Madison, 2015 | | 2015 |
| Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice EA Sawin, TJ De Wolfe, B Aktas, BM Stroup, SG Murali, JL Steele, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 309 (7 …, 2015 | 193 | 2015 |
| Glycomacropeptide shows prebiotic and immune modulating properties in phenylketonuria and wild type mice E Sawin, B Aktas, T DeWolfe, B Stroup, S Murali, J Steele, D Ney The FASEB Journal 29, 1010.2, 2015 | 3 | 2015 |
| Gut Microbial Alteration in MPTP Mouse Model of Parkinson Disease is Administration Regimen Dependent B Aktas Cellular and Molecular Neurobiology 43 (6), 2815-2829, 2023 | 5 | 2023 |
| Gut Microbiota Dysbiosis and COVID-19: Possible Links B Aktas Reference Module in Food Science, 2021 | | 2021 |
| Gut Microbiota Dysbiosis and COVID-19: Possible Links B Aktas Comprehensive Gut Microbiota 1, 535–544, 2022 | 7 | 2022 |
| Gut-lung axis and dysbiosis in COVID-19 B Aktaş, B Aslim Turkish journal of biology 44 (7), 265-272, 2020 | 164 | 2020 |
| İlaç Tedavilerinin Vajinal Mikrobiyota ile Karşılıklı Etkileşimi B AKTAŞ, F BİNLİ, B ASLIM Turkiye Klinikleri Veterinary Sciences-Pharmacology and Toxicology-Special …, 2018 | | 2018 |
| Impact of Exopolysaccharides (EPSs) of Lactobacillus gasseri strains isolated from human vagina on cervical tumor cells (HeLa) T Sungur, B Aslim, C Karaaslan, B Aktas Anaerobe 47, 137-144, 2017 | 137 | 2017 |
| Lactobacillus casei Cell‐Surface Components and Their Impact on Immunomodulation and Cecal Microbiata Composition B Aktas, TJ De Wolfe, N Safdar, BJ Darien, JL Steele The FASEB Journal 31, 892.2-892.2, 2017 | 1 | 2017 |
| Mesenchymal stem cell-probiotic communication: Beneficial bacteria in preconditioning A Mendi, B Aktaş, B Aslım Handbook of Stem Cell Therapy, doi.org/10.1007/978-981-16-6016-0_51-1, 2022 | 1 | 2022 |
| Neuropathy in COVID-19 associated with dysbiosis-related inflammation B Aktas, B Aslim Turkish Journal of Biology 45 (7), 390-403, 2021 | 7 | 2021 |
| Potential Use of Lactobacillus gasseri G10 Isolated from Human Vagina along with Intrauterine Devices (IUD) to Prevent Pathogen Colonization B AKTAS Sakarya University Journal of Science 26 (4), 776-788, 2022 | | 2022 |
| Shelf-life studies of putative probiotic Lacticaseibacillus casei strains in milk and model yogurt B Aktas, M Budinich, L Hoza, SA Rankin, JR Broadbent, JL Steele Food Science and Technology International 29 (7), 729-738, 2023 | 2 | 2023 |
| Shelf-life studies of putative probiotic Lactobacillus casei strains in milk and yogurt B Aktas, M Budinich, L Hoza, J Broadbent, JL Steele | | 2010 |
| The Effect of Lactobacillus casei 32G on the Mouse Cecum Microbiota and Innate Immune Response Is Dose and Time Dependent B Aktas, TJ De Wolfe, K Tandee, N Safdar, BJ Darien, JL Steele PloS one 10 (12), e0145784, 2015 | 34 | 2015 |
| The immune system in Parkinson’s disease: what we know so far C Roodveldt, L Bernardino, O Oztop-Cakmak, M Dragic, KE Fladmark, ... Brain, awae177, 2024 | | 2024 |
| The Impact of Lactobacillus casei on the Composition of the Cecal Microbiota and Innate Immune System Is Strain Specific B Aktas, TJ De Wolfe, N Safdar, BJ Darien, JL Steele PloS one 11 (5), e0156374, 2016 | 49 | 2016 |
